PATENT CLAIM ANALYSIS

Application Number: 16127509
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "021900"]

Abstract:
The invention provides pharmaceutical compositions comprising a farnesoid X receptor (FXR) agonist or caspase inhibitor and another therapeutic agent, e.g. PPAR-delta agonist in particular for treating or preventing liver diseases or disorders.

Claim (Index 13):
A method for preventing, delaying or treating a liver disease or disorder as defined in  claim 12 , in a patient in need therefor, comprising administering a therapeutically effective amount of i) a FXR agonist, e.g. as defined in  claim 4  or  5 , and of ii) an additional therapeutic agent, as defined in  claim 3 , each of the components of the combination being administered simultaneously or sequentially and in any order.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.12121
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16335662', '15612124', '15263033', '15598734', '15551224']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.744078706897795
- 35 USC 102 Novelty (BERT): 0.5184343416265836
- Combined Prediction Score: 0.7215142703706738
- Mean Citation Score: 232.16857200000004
- Max Citation Score: 309.541
- Similarity Product: 217.80977854704847

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test